PRESS RELEASE published on 08/15/2023 at 06:58, 1 year 3 months ago Medartis on track with 16% internal growth after 6 months
PRESS RELEASE published on 07/25/2023 at 09:00, 1 year 3 months ago Medartis 2023 half-year results presentation
PRESS RELEASE published on 04/21/2023 at 15:08, 1 year 7 months ago Medartis shareholders approve all proposals at the AGM 2023
PRESS RELEASE published on 03/17/2023 at 07:00, 1 year 8 months ago Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical
PRESS RELEASE published on 03/14/2023 at 06:31, 1 year 8 months ago Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth
PRESS RELEASE published on 02/16/2023 at 08:00, 1 year 9 months ago Medartis 2022 full-year results presentation
Published on 11/22/2024 at 23:55, 9 hours 20 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 45 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 10 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 45 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 17:53, 15 hours 21 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 19 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 15 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
